首页> 外文OA文献 >Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research

【2h】

Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research

机译：液体动态药物和1个临床试验：肿瘤学研究中的视角变化

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Nicola Silvestris; Gennaro Ciliberto; Paolo De Paoli; Giovanni Apolone; Maria Luisa Lavitrano; Marco A. Pierotti; Giorgio Stanta;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research [J] . Nicola Silvestris, Gennaro Ciliberto, Paolo De Paoli, Journal of experimental & clinical cancer research : . 2017,第1期

机译：液体动力医学和N-of-1临床试验：肿瘤学研究的观点转变
2. The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017) [J] . Talia Golan, Michele Milella, Aliza Ackerstein, Journal of experimental & clinical cancer research : . 2017,第1期

机译：个性化医学和免疫肿瘤学时代临床试验的不断变化：国际肿瘤学和血液肿瘤学国际临床大会报告（ICTO 2017）
3. The n-of-1 clinical trial: the ultimate strategy for individualizing medicine? [J] . Elizabeth O Lillie, Bradley Patay, Joel Diamant, Personalized Medicine . 2011,第2期

机译：第n个临床试验：个性化药物的最终策略是什么？
4. Statistics Clinical Trial Design: An Oncology Perspective [C] . Melissa C. Paoloni American College of Veterinary Internal Medicine Forum . 2010

机译：统计和临床试验设计：肿瘤学视角
5. Bayesian Modeling in Personalized Medicine with Applications to N-of-1 Trials [D] . Liao, Ziwei. 2021

机译：贝叶斯建模在个性化医学中，具有N-of-1试验
6. Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research [O] . Nicola Silvestris, Gennaro Ciliberto, Paolo De Paoli, 2017

机译：液体动力医学和N-of-1临床试验：肿瘤学研究的观点转变
7. Do you believe that N-of-1 trials (a clinical trial in which a single patient is the entire trial), are appropriate to evaluate the effectiveness of genomic therapies for rare and/or common genetic disorders? Do gene-editing/targeting therapies have the potential to expedite the advancement of personalized medicine? [O] . Ronald F. Carter 2017

机译：您是否认为N-1次试验（单人患者是整个试验的临床试验）是适合评估稀有和/或常见遗传疾病的基因组疗法的有效性？基因编辑/靶向疗法是否有可能加快个性化药物的进步？
8. Community Clinical Oncology Program and Minority-Based Community Clinical Oncology Program: Accomplishments in Cancer Clinical Trials [R] . 2011

机译：社区临床肿瘤学计划和基于少数民族的社区临床肿瘤学计划：癌症临床试验的成就

Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research

著录项

引文网络

相似文献

相关主题

期刊订阅